Sunshine Guojian Pharmaceutical Shanghai (SHA:688336) appointed Niu Hongmei as chief financial officer to succeed Sun Yongzhi, who resigned due to a job transfer.
Niu joined the drugmaker as financial manager in June 2017, according to a Wednesday filing with the Shanghai bourse.
Sun continues to serve as a director of Sunshine Guojian Pharmaceutical Shanghai.
Shares of the company closed 1% lower Wednesday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。